

| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Alendronate | FAERS: 4 | US FAERS | |
| 2 | Adzenys XR-ODT | FAERS: 1 | US FAERS | |
| 3 | Celecoxib | OFFSIDES | ||
| 4 | Ciclopirox | OFFSIDES | ||
| 5 | Ciclopirox | OFFSIDES | ||
| 6 | Dantrolene | OFFSIDES | ||
| 7 | Dapsone | OFFSIDES | ||
| 8 | Flurazepam | OFFSIDES | ||
| 9 | Ibuprofen | OFFSIDES | ||
| 10 | Pamidronate | OFFSIDES | ||
| 11 | Penicillin V | OFFSIDES | ||
| 12 | Pentamidine | OFFSIDES | ||
| 13 | Primidone | OFFSIDES | ||
| 14 | Pyridoxine | OFFSIDES | ||
| 15 | Salmeterol Xinafoate | OFFSIDES | ||
| 16 | Selenium | OFFSIDES | ||
| 17 | Sertraline | OFFSIDES | ||
| 18 | Zoledronic Acid | OFFSIDES | ||
| 19 | alfuzosin | OFFSIDES | ||
| 20 | carbidopa, levodopa drug combination | OFFSIDES | ||
| 21 | reviparin | OFFSIDES | ||
| 22 | temocapril hydrochloride | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.